Publications

Find coverage of the latest original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.

This activity is supported by an educational grant from AstraZeneca.

Anifrolumab, Mycophenolate mofetil, Sm-Tregs, CAR T-Cell, CV Risk factors,

October 2021

Arthritis Rheumatol 2017;69:376–86

One of the challenges of treating SLE is the limited efficacy and poor tolerability of current therapies.